Celldex Therapeutics, Inc. (CLDX)
NASDAQ·Healthcare·Biotechnology
$33.45
-0.62%
Mkt Cap $2.28B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $1.32M | $100.00K | -92.40% | -$1.00 | -$1.22 | -22.00% | — | — |
| Q4 2025 Nov 10, 2025 | $1.53M | — | — | -$0.88 | -$1.01 | -14.77% | — | — |
| Q3 2025 Aug 7, 2025 | $1.18M | $730.00K | -38.34% | -$0.86 | -$0.85 | +1.16% | — | — |
| Q2 2025 May 8, 2025 | $1.12M | $695.00K | -37.99% | -$0.75 | -$0.81 | -8.00% | — | — |
| Q1 2025 Feb 27, 2025 | $1.25M | $1.18M | -6.15% | -$0.73 | -$0.71 | +2.74% | — | — |
| Q4 2024 Nov 6, 2024 | $1.09M | $3.19M | +192.75% | -$0.69 | -$0.64 | +7.25% | — | — |
| Q3 2024 Aug 8, 2024 | $820.00K | $2.50M | +204.63% | -$0.59 | -$0.54 | +8.47% | — | — |
| Q2 2024 May 6, 2024 | $920.00K | $156.00K | -83.04% | -$0.67 | -$0.56 | +16.42% | — | — |
| Q1 2024 Feb 26, 2024 | $840.00K | $4.13M | +391.79% | -$0.76 | -$0.57 | +25.00% | — | — |
| Q4 2023 Nov 2, 2023 | $920.00K | $1.52M | +64.89% | -$0.67 | -$0.81 | -20.90% | — | — |
| Q3 2023 Aug 8, 2023 | $530.00K | $268.00K | -49.43% | -$0.65 | -$0.65 | +0.00% | — | — |
| Q2 2023 May 4, 2023 | $410.00K | $967.00K | +135.85% | -$0.63 | -$0.62 | +1.59% | — | — |
| Q1 2023 Feb 28, 2023 | $264.00K | $1.61M | +510.98% | -$0.59 | -$0.56 | +5.08% | — | — |
| Q4 2022 Nov 9, 2022 | $360.00K | $407.00K | +13.06% | -$0.57 | -$0.57 | +0.00% | — | — |
| Q3 2022 Aug 8, 2022 | $400.00K | $163.00K | -59.25% | -$0.43 | -$0.58 | -34.88% | — | — |
| Q2 2022 May 5, 2022 | $560.00K | $174.00K | -68.93% | -$0.46 | -$0.49 | -6.52% | — | — |
| Q1 2022 Feb 28, 2022 | $1.04M | $333.00K | -67.86% | -$0.42 | -$0.43 | -2.38% | — | — |
| Q4 2021 Nov 9, 2021 | $640.00K | $153.00K | -76.09% | -$0.35 | -$0.39 | -11.43% | — | — |
| Q3 2021 Aug 5, 2021 | $685.00K | $3.48M | +408.03% | -$0.40 | -$0.34 | +15.00% | — | — |
| Q2 2021 May 6, 2021 | $600.00K | $685.00K | +14.17% | -$0.32 | -$0.42 | -31.25% | — | — |